We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

316:HKEXOrient Overseas (International) Limited Analysis

Data as of 2026-05-24 - not real-time

NT$122.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

ASIX Electronics is trading well above its 20‑day SMA (≈110) and close to the 52‑week high of 124, indicating a strong bullish price trend. The technical picture is reinforced by a bullish MACD crossover and an RSI of 64, suggesting momentum but also a hint of overbought pressure. Volume, however, is on a decreasing trajectory, which may signal waning buying enthusiasm as the stock approaches the identified resistance at 124. Fundamentally, the company reports a negative revenue growth of about 5% and a DCF‑derived fair value of roughly 59 TWD, implying the market price of 122 TWD is significantly overvalued. While the PE ratio of 33.5 sits below the industry average of 39.5, the high price‑to‑book multiple (≈4) and an 82% dividend payout ratio raise concerns about valuation and dividend sustainability. The balance sheet is strong with ample cash and minimal debt, yet the high payout and modest free cash flow suggest limited cushion for future dividend hikes. Overall, the stock exhibits strong short‑term momentum but faces valuation headwinds, modest growth prospects, and elevated volatility (≈67% 30‑day).

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price near technical resistance
  • Decreasing volume momentum
  • Significant overvaluation vs DCF

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Weak revenue growth
  • Strong cash position but high dividend payout
  • Sector volatility and cyclical risk

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Attractive dividend yield but sustainability concerns
  • Fundamental overvaluation persists
  • Potential upside from semiconductor cycle recovery

Key Metrics & Analysis

Financial Health

Revenue Growth-5.30%
Profit Margin24.19%
P/E Ratio33.5
ROE11.74%
ROA7.40%
Debt/Equity0.56
P/B Ratio4.0
Op. Cash FlowNT$276.8M
Free Cash FlowNT$152.1M
Industry P/E39.5

Technical Analysis

TrendBullish
RSI64.0
SupportNT$103.00
ResistanceNT$124.00
MA 20NT$110.78
MA 50NT$102.16
MA 200NT$96.54
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair ValueNT$59.42
GradeOvervalued
TypeValue
Dividend Yield2.62%

Risk Assessment

Beta0.19
Volatility67.33%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.